Quick Search:       Advanced Search
Effects of bifidobacteria on high-fat diet-induced non-alcoholic fatty liver disease in C57BL/6 mice
Received:February 11, 2022  Revised:June 01, 2022  Click here to download the full text
Citation of this paper:SHI Ying,LABA Pu-chi,ZHANG Dan-ying,WENG Shu-qiang,LIU Xin-yi,WANG Hao-qi.Effects of bifidobacteria on high-fat diet-induced non-alcoholic fatty liver disease in C57BL/6 mice[J].Chinese Journal of Clinical Medicine,2022,29(3):473-480
Hits: 1007
Download times: 281
Author NameAffiliationE-mail
SHI Ying Department of Gastroenterology and Hepatology, Fengxian District Traditional Chinese Medicine Hospital, Shanghai 201400, China  
LABA Pu-chi Department of Gastroenterology and Hepatology, Shigatse People's Hospital, Shigatse 857000, Tibet, China  
ZHANG Dan-ying Department of Gastroenterology and Hepatology, Zhongshan Hopsital, Fudan University, Shanghai 200032, China  
WENG Shu-qiang Department of Gastroenterology and Hepatology, Zhongshan Hopsital, Fudan University, Shanghai 200032, China weng.shuqiang@zs-hospital.sh.cn 
LIU Xin-yi Department of Gastroenterology and Hepatology, Zhongshan Hopsital, Fudan University, Shanghai 200032, China  
WANG Hao-qi Department of Gastroenterology and Hepatology, Zhongshan Hopsital, Fudan University, Shanghai 200032, China wang.haoqi@zs-hospital.sh.cn 
Abstract:Objective To explore whether bifidobacteria attenuates high-fat diet-induced non-alcoholic fatty liver disease (NAFLD) in C57BL/6 mice by altering the gut microbiota, reducing local intestinal inflammation, and modulating systemic inflammation. Methods 32 male C57BL/6 mice were randomly allocated into four groups:common feed group, common feed group with bifidobacteria, high fat diet group, high fat diet group with bifidobacteria, each group is divided into 2 cages, 4 for each cage. Serum glucose and lipid metabolism and liver function levels in mice were detected. Mouse liver steatosis was assessed by Oil red O staining and hematoxylin-eosin (H-E) staining. Expression of TNF-α, IL-6, ZO-1 and occludin in mouse ileum and colon tissue by real time PCR.Gut microbiota profiles were established through 16SrRNA amplicon sequencing. Results The degree of liver steatosis in C57BL/6 mice in the bifidobacteria intervention group was significantly lower than that in the high-fat diet-fed group. The expression of inflammatory factors TNF-α and IL-6 in the bifidobacteria intervention group was significantly decreased. The species abundance and diversity of gut microbiota was decreased in NAFLD group. The results of PcoA and NMDS showed that there were significant differences in the composition of the flora among the groups. The gut microbial structure was changed, and abundance of Firmicutes was increased significantly after treated with bifidobacteria. Conclusion Taken together, these data suggest that bifidobacteria has a protective effect on NAFLD via changing the components of gut microbiota.
keywords:non-alcoholic fatty liver disease  bifidobacteria  gastro intestinal microbiome
HTML  View Full Text  View/Add Comment  Download reader